Skip to content

Insider · CIK 0001646558

David Colleran

officer

Files at ANIK (Anika Therapeutics, Inc.). First filing -, latest -.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Mar 17, 2025ANIK
Anika Therapeutics, Inc.
MOption exercise
Common Stock
+6,448$0.00$049,847Mar 18, 2025
Mar 17, 2025ANIK
Anika Therapeutics, Inc.
FTax withholding
Common Stock
-1,893$15.91$30k47,954Mar 18, 2025
Mar 14, 2025ANIK
Anika Therapeutics, Inc.
AGrant or award
Restricted Stock Unitderivative
+28,165$0.00$028,165Mar 18, 2025
Mar 14, 2025ANIK
Anika Therapeutics, Inc.
AGrant or award
Restricted Stock Unitderivative
+13,669$0.00$013,669Mar 18, 2025
Mar 17, 2025ANIK
Anika Therapeutics, Inc.
MOption exercise
Restricted Stock Unitderivative
-6,448$0.00$012,897Mar 18, 2025
Mar 11, 2025ANIK
Anika Therapeutics, Inc.
MOption exercise
Common Stock
+7,663$0.00$045,649Mar 13, 2025
Mar 11, 2025ANIK
Anika Therapeutics, Inc.
FTax withholding
Common Stock
-2,250$16.79$38k43,399Mar 13, 2025
Mar 11, 2025ANIK
Anika Therapeutics, Inc.
MOption exercise
Restricted Stock Unitderivative
-7,663$0.00$00Mar 13, 2025
Mar 10, 2025ANIK
Anika Therapeutics, Inc.
MOption exercise
Common Stock
+5,465$0.00$039,590Mar 11, 2025
Mar 10, 2025ANIK
Anika Therapeutics, Inc.
FTax withholding
Common Stock
-1,604$16.62$27k37,986Mar 11, 2025
Mar 10, 2025ANIK
Anika Therapeutics, Inc.
MOption exercise
Restricted Stock Unitderivative
-5,465$0.00$05,465Mar 11, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

David Colleran: insider trades and track record | InsiderTell